International Congress Barcelona 2013

Saturday, 07.09.2013
Sunday, 08.09.2013
Monday, 09.09.2013
Tuesday, 10.09.2013
Wednesday, 11.09.2013

Citations should be made in the following way: Authors. Title. Eur Respir J 2013; 42: Suppl. 57, abstract number.



Advances in the therapy of lung cancer

Oral Presentation
Chairs: F. Gamarra (Munich, Germany), G. Hardavella (Athens, Greece)
LATE-BREAKING ABSTRACT: Effect of training on maximal oxygen uptake and muscular strength after lung cancer surgery - A randomized controlled trial
E. Edvardsen, O. H. Skjonsberg, F. Borchsenius, S. A Anderssen (Oslo, Norway)
Congress or journal article abstract
Congress or journal article abstract
Cetuximab administered through pulmonary route in a mice model of lung tumor
L. Guilleminault, F. Paul, S. Lerondel, V. Schubnel, J. Montharu, M. De Monte, A. Lepape, E. Lemarié, N. Heuzé-Vourc'h (Tours, Orléans, France)
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
LUX-Lung 6: A randomized, open-label, phase III study of afatinib (A) vs gemcitabine/cisplatin (GC) as first-line treatment for Asian patients (pts) with EGFR mutation-positive (EGFR M+) advanced adenocarcinoma of the lung
Y. L. Wu, C. Zhou, C. P. Hu, J. Feng, S. Lu, Y. Huang, W. Li, M. Hou, J. H. Shi, K. Y. Lee, D. Massey, Y. Shi, J. J. Chen, V. Zazulina, S. L. Geater (Guangzhou, Shanghai, Changsha, Nanjing, Kunming, Changchun, Chengdu, Linyi, China; Seoul, Republic Of Korea; Bracknell, United Kingdom; Songkhla, Thailand)
Congress or journal article abstractSlide presentationE-poster
Congress or journal article abstractSlide presentationE-poster
Ifosfamide (IFO) is a valuable alternative to cisplatin (CDDP) for first-line chemotherapy (CT) in advanced non-small cell lung cancer (NSCLC): A meta-analysis
T. Berghmans, M. Paesmans, A. P. Meert, M. Tiseo, J. P. Sculier (Brussels, Belgium; Parma, Italy)
Congress or journal article abstract
Congress or journal article abstract
Pemetrexed in advanced non-small cell lung cancer patients with idiopathic pulmonary fibrosis
M. Kato, T. Shukuya, F. Takahashi, A. Inagaki, R. Kanemaru, R. Ko, S. Yagishita, N. Fariz, I. Kobayashi, A. Murakami, Y. Hoshika, K. Muraki, R. Koyama, N. Shimada, A. Sakuraba, K. Takahashi (Japan)
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
Treatment of advanced non-small cell lung cancer with trofosfamide
A. Reissig, M. Walther (Jena, Germany)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
CyberKnife radiosurgery for early stage nonsmall cell lung cancer
B. Komurcuoglu, A. Olmezoglu, H. Koparal, E. Yalniz (Izmir, Turkey)
Congress or journal article abstract
Congress or journal article abstract
The role of second line chemotherapy in small cell lung cancer: A retrospective analysis
E. Boutsikou, P. Zarogoulidis, K. Porpodis, D. Latsios, M. Kipourou, K. Zarogoulidis (Thessaloniki, Greece)
Congress or journal article abstract
Congress or journal article abstract